Amantadine
- Product NDC
- 82804-267
- 11-digit product format
- 828040267
- Labeler code
- 82804
- Product ID
- 82804-267_7aa6bc18-1cee-4b6d-b7c3-0bac6a924ece
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amantadine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Proficient Rx LP
- Application
- ANDA214284
- Marketing category
- ANDA
- Marketing start
- 2020-10-20
- Substance
- AMANTADINE HYDROCHLORIDE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Amantadine
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AMANTADINE HYDROCHLORIDE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | M6Q1EO9TD0 |
| Rxcui | 849395 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 82804-267-20 | Amantadine | 20 in 1 BOTTLE | TABLET | 20 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 82804-267-20 | 82804026720 | 20 TABLET in 1 BOTTLE (82804-267-20) | 20 tablet | 2026-02-18 | No | No | Current |